IDI2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, IDI2 mutation is significantly associated with the RNA expression of many other genes, with 57 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible IDI2-associated genes across cancer lineages are RNA5SP329, RNU6-905P, and OR5AP2. Each is linked with IDI2 in more than 1 cancer types. Because this analysis shows association rather than direction, both IDI2-to-partner and partner-to-IDI2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP329 grouped by IDI2-low versus IDI2-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (IDI2→partner) and Y-score (partner→IDI2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLCARNA5SP329 →+0.349+5.106<.001.00832
SKCMRNU6-905P →+0.366+5.513<.001.00432
SKCMOR5AP2 →+0.311+5.097.002.00832
SKCMIQCF5-AS1 →+0.024+5.362<.001.00531
SKCMANKRD26P2 →+0.054+5.362<.001.00531
BLCAPDE2A-AS1 →+0.088+4.973<.001.00931
Each partner links to its Q-omics profile. Showing the 6 strongest of 57 associations by consensus.

RNA5SP329 by IDI2 expression — BLCA

Box plot of RNA5SP329 in IDI2-low vs IDI2-high samples in BLCA.

Explore this box plot interactively →

Exploration